Antimalarial Drug development

Evaluation of new pharmacophores for their blood schizontocidal activity against P.falciparum

Experimental in vivo antimalarial profile studies against drug sensitive and resistant malaria parasites in mouse and monkey model

Exploration of new drugs for cerebral malaria

Combinations studies to explore new synergistic drug partners

Development/assessment of nanoformulations for antimalarials
Cerebral malaria (CM)

Development of in vitro/in vivo models for CM

CM related pathological/immunological mechanistic studies

Study of neurotransmitters involved in CM
Studies linked to drug resistance in malaria

Evaluation of genetic markers involved in drug resistance

Drug resistance reversal studies
Action mechanisms of antimalarials

Studies of antimalarial induced apoptotic pathway in malaria parasites

β hematin formation inhibition studies
Protein Identification

Identification of proteins involved in malaria pathogenesis